Opportunities and Risks of a Single-Trial Default for FDA Drug Approval
This Viewpoint describes potential concerns and opportunities with a single-trial default for US Food and Drug Administration (FDA) drug approval.
from JAMA Health Forum New Online https://ift.tt/RfsE7qn
from JAMA Health Forum New Online https://ift.tt/RfsE7qn
Comments
Post a Comment